BridgeMD
New treatment option for Chemotherapy Effect
Official title Prevalence of Long-term Dental Effects of Chemotherapy in Childhood Cancer Survivors Diagnosed With Cancer Before the Age of 10
ClinicalTrials.gov ID: NCT06517927
What this study is testing
- What it's testing
- To date, there are no methods for assessing the risk of oral developmental defects that could predict long-term adverse effects in childhood cancer survivors. Having such a method at our disposal would enable us to better assess the risk to develop those defects and will help us provide new prevention and treatment strategies to ensure a healthy oral development.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 36
You may be able to join if
- age below 10 at cancer diagnosis (for the CCS group).
- Chemotherapy must have been used to treat the patient (For the CCS group).
- The patient is 12 years old or older at the time of the follow-up appointment of the present study
You likely can't join if
- A patient who was diagnosed and treated after 10 years old.
- Patient below 12 years old at time of study recruitment
- Patients with syndrome or diseases that involve teeth impairment\
- Pregnant patient
- Refusal or inaptitude to undergo dental and radiographic examination
The study team makes the final eligibility decision.
Where it's taking place
- Brussels, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 36 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brussels, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.